Clinton Announces US FDA Reform Proposals

26 March 1995

Clinton Announces FDA Reform Proposals

The US Clinton Administration has announced proposals for changes in five areas of Food and Drug Administration responsibilities, under its Reinventing Government initiative. The aims of the reforms, which are entitled Reinventing Drug and Device Regulation, are "to protect people not bureaucracy, promote results not rules, get action not rhetoric, whenever possible to try to embrace common sense," according to President Clinton.

The Administration proposes that: - regulations covering reporting of changes to manufacturing of drugs and biologics should be eased, permitting companies to change the way they manufacture already-approved products without prior FDA approval if the risks are negligible. This would allow companies to modernize their facilities and practices more easily;

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight